Published in J Am Acad Dermatol on May 01, 2008
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob (2006) 2.55
Proliferating trichilemmal tumors: a review of the literature. Dermatol Surg (2007) 2.31
Combination treatment of invasive fungal infections. Clin Microbiol Rev (2005) 1.59
Cutaneous epithelioid angiomatous nodule: a case series and proposed classification. Am J Dermatopathol (2008) 1.49
Physician signatures. South Med J (2008) 1.39
Pruritic red papules on the right flank: challenge. Am J Dermatopathol (2015) 1.39
Giant verrucous nodules in a patient with tuberculosis. Am J Dermatopathol (2009) 1.38
In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program. Antimicrob Agents Chemother (2005) 1.17
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrob Agents Chemother (2008) 1.11
PEComas: a review with emphasis on cutaneous lesions. Semin Diagn Pathol (2009) 1.11
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program. J Clin Microbiol (2006) 1.04
Intralymphatic histiocytosis. A clinicopathologic study of 16 cases. Am J Dermatopathol (2009) 0.98
Spontaneous regression of langerhans cell histiocytosis in a neonate with multiple bony lesions. J Pediatr Hematol Oncol (2008) 0.95
Bactericidal activity and resistance development profiling of dalbavancin. Antimicrob Agents Chemother (2007) 0.95
Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders. Arch Dermatol Res (2011) 0.94
Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs. Diagn Microbiol Infect Dis (2007) 0.91
The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients. Dermatol Surg (2011) 0.90
Generalized granuloma annulare as an initial manifestation of chronic myelomonocytic leukemia: a report of 2 cases. Am J Dermatopathol (2008) 0.88
Development of anidulafungin for disk diffusion susceptibility testing against Candida spp. Diagn Microbiol Infect Dis (2007) 0.88
Lasp1 gene disruption is linked to enhanced cell migration and tumor formation. Physiol Genomics (2009) 0.88
Pseudolymphomatous and lichenoid reaction to a red tattoo: a case report. Cutis (2011) 0.87
Adjunctive radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion. J Surg Oncol (2011) 0.87
Transglutaminases: the missing link in nephrogenic systemic fibrosis. Am J Dermatopathol (2007) 0.87
A linear orofacial macule. Am J Dermatopathol (2008) 0.86
Utilization of Mohs micrographic surgery in a patient with onychomatricoma. Dermatol Surg (2015) 0.84
Interstitial granulomatous dermatitis secondary to acute promyelocytic leukemia. Am J Dermatopathol (2008) 0.83
Squamous cell carcinoma in situ arising in the setting of erythema ab igne. J Drugs Dermatol (2008) 0.83
Mycosis fungoides: an updated review of clinicopathologic variants. Am J Dermatopathol (2014) 0.83
New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy. J Drugs Dermatol (2008) 0.83
Cutaneous marginal zone lymphoma arising in the setting of erythema ab igne. J Am Acad Dermatol (2010) 0.82
Retrospective study of intraepidermal nerve fiber distribution in biopsies of patients with nummular eczema. Am J Dermatopathol (2011) 0.81
Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother (2007) 0.80
Poorly differentiated carcinoma arising in the setting of erythema ab igne. Am J Dermatopathol (2013) 0.80
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels. Antimicrob Agents Chemother (2009) 0.79
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole. Mycopathologia (2006) 0.78
Refractory Hailey-Hailey disease successfully treated with sandpaper dermabrasion. Skinmed (2011) 0.76
Ossifying dermatofibroma with osteoclast-like giant cells: report of a case and literature review. Am J Dermatopathol (2009) 0.75
Mycosis fungoides: new insights into an old problem. Arch Dermatol (2002) 0.75
Pruritic red papules of the right flank. Am J Dermatopathol (2015) 0.75
Recurrent squamous cell carcinoma presenting as facial nerve palsy in the setting of organ transplantation. Dermatol Surg (2006) 0.75
Pediatric Patient With Chronic Generalized Blisters: Challenge. Am J Dermatopathol (2017) 0.75
Melanocytic Nevi of Special Sites. Am J Dermatopathol (2016) 0.75
Flesh-colored papule on the areola. Int J Dermatol (2013) 0.75
Erythematous lesions on the back of a man: challenge. Erythema ab igne. Am J Dermatopathol (2011) 0.75
Filamentous bacteria masquerading as fungi: a diagnostic pitfall in direct smear interpretation with report of two cases. J Clin Pathol (2011) 0.75
Challenge. What is your diagnosis? Answer. Primary nodal diffuse large B-cell lymphoma with secondary cutaneous involvement. Am J Dermatopathol (2009) 0.75
Malignant perifollicular atypical fibroxanthoma treated with Mohs surgery. Dermatol Surg (2007) 0.75
It seems that it was yesterday. Am J Dermatopathol (2009) 0.75
Fungal foes: Lacazia loboi. Cutis (2009) 0.75
Video game induced knuckle pad. Pediatr Dermatol (2006) 0.75
A 41-year-old woman with a scaly erythematous plaque admixed with erosions on the groin, back, and legs: challenge. Nutritional deficiency. Am J Dermatopathol (2010) 0.75
Early histopathologic changes in grover disease. Am J Dermatopathol (2010) 0.75
Proposed quality control ranges for 2-microg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values. Diagn Microbiol Infect Dis (2008) 0.75
Composite B-cell and T-cell lineage post-transplant lymphoproliferative disorder of the lung with unusual cutaneous manifestations of mycosis fungoides. Am J Dermatopathol (2012) 0.75
Paecilomyces lilacinus infection with a sporotrichoid pattern in a renal transplant patient. J Drugs Dermatol (2007) 0.75
Epidermolytic hyperkeratosis and congenital platelike osteoma cutis in a child. Cutis (2011) 0.75
Altered Morphology and Immunohistochemical Characteristics in Metastatic Malignant Melanoma After Therapy With Vemurafenib. Am J Dermatopathol (2016) 0.75
Firm nodule on the shoulder. Arch Dermatol (2012) 0.75
Is Tumor of Follicular Infundibulum a Reaction to Dermal Scarring? Am J Dermatopathol (2015) 0.75
Skin retraction as a marker for aggressive basal cell carcinoma. Dermatol Surg (2013) 0.75
The importance of avoiding electrosurgical artifact at the margins of melanoma excisions. J Surg Oncol (2007) 0.75
Clustered painful pink papules with chest tightness. Int J Dermatol (2014) 0.75
Acute mental status change in an immunocompromised patient. Clin Infect Dis (2010) 0.75
Atypical fibroxanthoma with keloidal collagen. Am J Dermatopathol (2010) 0.75
A true molluscum pendulum. Int J Dermatol (2007) 0.75
Ossifying plexiform tumor: report of two new cases. Am J Dermatopathol (2008) 0.75
Bullous fixed drug eruption caused by flecainide. J Am Acad Dermatol (2008) 0.75
Pediatric Patient With Chronic Generalized Blisters: Answer. Am J Dermatopathol (2017) 0.75
The Pachuco mark and similar tattoos. South Med J (2009) 0.75
Dabigatran etexilate: clinical implications in dermatologic surgery. Dermatol Surg (2012) 0.75
Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels. Arch Dermatol (2009) 0.75
Erythematous friable papule under the great toenail. Cutis (2015) 0.75